These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18662098)

  • 1. Optimisation of the post-validation process: the report and recommendations of ECVAM Workshop 67.
    Bottini AA; Alepee N; Phillips B; Gribaldo L; De Silva O; Hartung T; Hendriksen C; Kuil J; Pazos P; Rhein C; Schiffelers MJ; Stokes W; Theobald A; Vidal JM; Van de Sandt H; Breier S; Sintes JR; Blaauboer B
    Altern Lab Anim; 2008 Jul; 36(3):353-66. PubMed ID: 18662098
    [No Abstract]   [Full Text] [Related]  

  • 2. Points of reference in the validation process: the report and recommendations of ECVAM Workshop 66.
    Hoffmann S; Edler L; Gardner I; Gribaldo L; Hartung T; Klein C; Liebsch M; Sauerland S; Schechtman L; Stammati A; Nikolaidis E
    Altern Lab Anim; 2008 Jul; 36(3):343-52. PubMed ID: 18662097
    [No Abstract]   [Full Text] [Related]  

  • 3. Three Rs Approaches in Marine Biotoxin Testing. The Report and Recommendations of a joint ECVAM/DG SANCO Workshop (ECVAM Workshop 54).
    Hess P; Grune B; Anderson DB; Aune T; Botana LM; Caricato P; van Egmond HP; Halder M; Hall S; Lawrence JF; Moffat C; Poletti R; Richmond J; Rossini GP; Seamer C; Vilageliu JS;
    Altern Lab Anim; 2006 May; 34(2):193-224. PubMed ID: 16704292
    [No Abstract]   [Full Text] [Related]  

  • 4. Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. The report and recommendations of ECVAM Workshop 52.
    Netzeva TI; Worth A; Aldenberg T; Benigni R; Cronin MT; Gramatica P; Jaworska JS; Kahn S; Klopman G; Marchant CA; Myatt G; Nikolova-Jeliazkova N; Patlewicz GY; Perkins R; Roberts D; Schultz T; Stanton DW; van de Sandt JJ; Tong W; Veith G; Yang C
    Altern Lab Anim; 2005 Apr; 33(2):155-73. PubMed ID: 16180989
    [No Abstract]   [Full Text] [Related]  

  • 5. Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies.
    Coecke S; Goldberg AM; Allen S; Buzanska L; Calamandrei G; Crofton K; Hareng L; Hartung T; Knaut H; Honegger P; Jacobs M; Lein P; Li A; Mundy W; Owen D; Schneider S; Silbergeld E; Reum T; Trnovec T; Monnet-Tschudi F; Bal-Price A
    Environ Health Perspect; 2007 Jun; 115(6):924-31. PubMed ID: 17589601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS).
    Kinsner-Ovaskainen A; Maxwell G; Kreysa J; Barroso J; Adriaens E; Alépée N; Berg N; Bremer S; Coecke S; Comenges JZ; Corvi R; Casati S; Dal Negro G; Marrec-Fairley M; Griesinger C; Halder M; Heisler E; Hirmann D; Kleensang A; Kopp-Schneider A; Lapenna S; Munn S; Prieto P; Schechtman L; Schultz T; Vidal JM; Worth A; Zuang V
    Altern Lab Anim; 2012 Jul; 40(3):175-81. PubMed ID: 22943518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ECVAM in promoting the regulatory acceptance of alternative methods in the European Union. European Centre for the Validation of Alternative Methods.
    Worth AP; Balls M
    Altern Lab Anim; 2001; 29(5):525-35. PubMed ID: 11604096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58.
    Balls M; Amcoff P; Bremer S; Casati S; Coecke S; Clothier R; Combes R; Corvi R; Curren R; Eskes C; Fentem J; Gribaldo L; Halder M; Hartung T; Hoffmann S; Schectman L; Scott L; Spielmann H; Stokes W; Tice R; Wagner D; Zuang V;
    Altern Lab Anim; 2006 Dec; 34(6):603-20. PubMed ID: 17266393
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro models of the intestinal barrier. The report and recommendations of ECVAM Workshop 46. European Centre for the Validation of Alternative methods.
    Le Ferrec E; Chesne C; Artusson P; Brayden D; Fabre G; Gires P; Guillou F; Rousset M; Rubas W; Scarino ML
    Altern Lab Anim; 2001; 29(6):649-68. PubMed ID: 11709041
    [No Abstract]   [Full Text] [Related]  

  • 10. Barriers to validation: a report by the European Partnership fo Alternative Approaches to Animal Testing (EPAA) Working Group 5.
    Ahr HJ; Alepée N; Breier S; Brekelmans C; Cotgreave I; Gribaldo L; Dal Negro G; De Silva O; Hartung T; Lacerda A; Leblanc B; Lecerf C; Linge JP; Louhimies S; Manou I; Maxwell G; Müller KK; Pape W; Redhead K; Schröder KR; Sladowski D; van der Jagt K; Vanparys P
    Altern Lab Anim; 2008 Sep; 36(4):459-64. PubMed ID: 18826335
    [No Abstract]   [Full Text] [Related]  

  • 11. The potential of physicochemical and immunochemical assays to replace animal tests in the quality control of toxoid vaccines. The report and recommendations of ECVAM workshop 61.
    Metz B; Brunel F; Chamberlin C; van der Gun J; Halder M; Jiskoot W; Kersten G; van Opstal O; Petersen JW; Ravetkar SD; Redhead K; Schwanig M; Wilhelmsen ES; Vann WF; Hendriksen C
    Altern Lab Anim; 2007 Jun; 35(3):323-31. PubMed ID: 17650951
    [No Abstract]   [Full Text] [Related]  

  • 12. Strategies to replace in vivo acute systemic toxicity testing. The report and recommendations of ECVAM Workshop 50.
    Gennari A; van den Berghe C; Casati S; Castell J; Clemedson C; Coecke S; Colombo A; Curren R; Dal Negro G; Goldberg A; Gosmore C; Hartung T; Langezaal I; Lessigiarska I; Maas W; Mangelsdorf I; Parchment R; Prieto P; Sintes JR; Ryan M; Schmuck G; Stitzel K; Stokes W; Vericat JA; Gribaldo L;
    Altern Lab Anim; 2004 Oct; 32(4):437-59. PubMed ID: 15651930
    [No Abstract]   [Full Text] [Related]  

  • 13. Replacement, reduction or refinement of animal use in the quality control of veterinary vaccines: development, validation and implementation.
    van der Kamp MD
    Dev Biol Stand; 1996; 86():73-6. PubMed ID: 8785994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ECVAM's approach to intellectual property rights in the validation of alternative methods.
    Linge JP; Hartung T
    Altern Lab Anim; 2007 Aug; 35(4):441-6. PubMed ID: 17850189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ECVAM workshops: a critical assessment of their impact on the development, validation and acceptance of alternative methods.
    Combes RD
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():151-65. PubMed ID: 12513668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming barriers to validation of non-animal partial replacement methods/Integrated Testing Strategies: the report of an EPAA-ECVAM workshop.
    Kinsner-Ovaskainen A; Akkan Z; Casati S; Coecke S; Corvi R; Dal Negro G; De Bruijn J; De Silva O; Gribaldo L; Griesinger C; Jaworska J; Kreysa J; Maxwell G; McNamee P; Price A; Prieto P; Schubert R; Tosti L; Worth A; Zuang V
    Altern Lab Anim; 2009 Sep; 37(4):437-44. PubMed ID: 19807215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Good Cell Culture Practice. ECVAM Good Cell Culture Practice Task Force Report 1.
    Hartung T; Balls M; Bardouille C; Blanck O; Coecke S; Gstraunthaler G; Lewis D;
    Altern Lab Anim; 2002; 30(4):407-14. PubMed ID: 12234246
    [No Abstract]   [Full Text] [Related]  

  • 18. Guidance on good cell culture practice. a report of the second ECVAM task force on good cell culture practice.
    Coecke S; Balls M; Bowe G; Davis J; Gstraunthaler G; Hartung T; Hay R; Merten OW; Price A; Schechtman L; Stacey G; Stokes W;
    Altern Lab Anim; 2005 Jun; 33(3):261-87. PubMed ID: 16180980
    [No Abstract]   [Full Text] [Related]  

  • 19. FRAME and the validation process.
    Balls M; Clothier R
    Altern Lab Anim; 2009 Dec; 37(6):631-40. PubMed ID: 20104999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternatives to the Use of Animals in Higher Education: The Report and Recommendations of ECVAM (European Centre for the Validation of Alternate Methods) Workshop 33.
    van der Valk J; Dewhurst D; Hughes I; Atkinson J; Balcombe J; Braun H; Gabrielson K; Gruber F; Miles J; Nab J; Nardi J; van Wilgenburg H; Zinko U; Zurlo J
    Altern Lab Anim; 1999; 27(1):39-52. PubMed ID: 11660636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.